Isabel Boivin

1.3k total citations
20 papers, 536 citations indexed

About

Isabel Boivin is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Isabel Boivin has authored 20 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Isabel Boivin's work include Acute Myeloid Leukemia Research (14 papers), Protein Degradation and Inhibitors (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Isabel Boivin is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Protein Degradation and Inhibitors (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Isabel Boivin collaborates with scholars based in Canada, Germany and United States. Isabel Boivin's co-authors include Guy Sauvageau, Josée Hébert, Vincent‐Philippe Lavallée, Sébastien Lemieux, Geneviève Boucher, Bernhard Lehnertz, Nadine Mayotte, Jana Krošl, Anne Marinier and Jalila Chagraoui and has published in prestigious journals such as Blood, Science Advances and Journal of Hepatology.

In The Last Decade

Isabel Boivin

19 papers receiving 530 citations

Peers

Countries citing papers authored by Isabel Boivin

Since Specialization

Citations

This map shows the geographic impact of Isabel Boivin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Boivin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Boivin more than expected).

Fields of papers citing papers by Isabel Boivin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Boivin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Boivin. The network helps show where Isabel Boivin may publish in the future.

Co-authorship network of co-authors of Isabel Boivin

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Boivin. A scholar is included among the top collaborators of Isabel Boivin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Boivin. Isabel Boivin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibition 2025 ·EMBO Reports ·Céline Moison, (unknown), (unknown), Doris A. Schuetz, Jean-François Spinella, Steven Girard, Bounkham Thavonekham, Jalila Chagraoui, Aurélie Durand, Simon Fortier, Tara MacRae, Éric Bonneil, (unknown), Nadine Mayotte, Isabel Boivin, Pierre Thibault, Josée Hébert, Réjean Ruel, Anne Marinier, Guy Sauvageau	0
2	SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia 2024 ·Science Advances ·Céline Moison, (unknown), Julie Schmitt, Simon Girard, Jean-François Spinella, Simon Fortier, Isabel Boivin, (unknown), Bounkham Thavonekham, Tara MacRae, Nadine Mayotte, Éric Bonneil, Mark D. Wittman, James Carmichael, Réjean Ruel, Pierre Thibault, Josée Hébert, Anne Marinier, Guy Sauvageau	18
3	DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5/del(5q) AML 2023 ·Leukemia ·Jean-François Spinella, Jalila Chagraoui, Céline Moison, Vincent‐Philippe Lavallée, Isabel Boivin, (unknown), Sylvie Lavallée, Guillaume Richard‐Carpentier, François Béliveau, Josée Hébert, Guy Sauvageau	4
4	Disruption of Intracellular Metal Homeostasis As a Vulnerability in SF3B1 Mutated AML 2022 ·Blood ·Céline Moison, (unknown), Julie Schmitt, Simon Girard, Simon Fortier, Isabel Boivin, Jean-François Spinella, Tara MacRae, Réjean Ruel, Josée Hébert, Anne Marinier, Guy Sauvageau	1
5	HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition 2022 ·Blood Advances ·Céline Moison, Jean-François Spinella, Jalila Chagraoui, Vincent‐Philippe Lavallée, Bernhard Lehnertz, Clarisse Thiollier, Isabel Boivin, Nadine Mayotte, Tara MacRae, Anne Marinier, Josée Hébert, Guy Sauvageau	9
6	HLF expression defines the human hematopoietic stem cell state 2021 ·Blood ·Bernhard Lehnertz, Jalila Chagraoui, Tara MacRae, Elisa Tomellini, Sophie Corneau, Nadine Mayotte, Isabel Boivin, Aurélie Durand, (unknown), Guy Sauvageau	42
7	High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML 2020 ·Blood ·Laura Simon, Jean-François Spinella, Chi‐Yuan Yao, Vincent‐Philippe Lavallée, Isabel Boivin, Geneviève Boucher, Éric Audemard, Marie-Ève Bordeleau, Sébastien Lemieux, Josée Hébert, Guy Sauvageau	51
8	Complex karyotype AML displays G2/M signature and hypersensitivity to PLK1 inhibition 2019 ·Blood Advances ·Céline Moison, Vincent‐Philippe Lavallée, Clarisse Thiollier, Bernhard Lehnertz, Isabel Boivin, Nadine Mayotte, Yves Gareau, Mélanie Fréchette, (unknown), Sophie Corneau, Sylvie Lavallée, Sébastien Lemieux, Anne Marinier, Josée Hébert, Guy Sauvageau	20
9	Genetic characterization of ABT-199 sensitivity in human AML 2019 ·Leukemia ·(unknown), Céline Moison, Clarisse Thiollier, Jana Krošl, Marie-Ève Bordeleau, Bernhard Lehnertz, Vincent‐Philippe Lavallée, Tara MacRae, Nadine Mayotte, (unknown), Geneviève Boucher, Jean-François Spinella, Isabel Boivin, Giovanni D’Angelo, Sylvie Lavallée, Anne Marinier, Sébastien Lemieux, Josée Hébert, Guy Sauvageau	65
10	Chemogenomic Profiling of Complex Karyotype AML Reveals a Novel Susceptibility to G2/M Checkpoint Inhibition Mediated By HMGA2 Overexpression 2018 ·Blood ·Céline Moison, Vincent‐Philippe Lavallée, Clarisse Thiollier, Jean-François Spinella, Isabel Boivin, Sébastien Lemieux, Anne Marinier, Josée Hébert, Guy Sauvageau	1
11	Genetic Characterization of ABT-199 Sensitivity in Human AML 2018 ·Blood ·Marie-Ève Bordeleau, (unknown), Clarisse Thiollier, Jana Krošl, Bernhard Lehnertz, Vincent‐Philippe Lavallée, Tara MacRae, (unknown), Geneviève Boucher, Isabel Boivin, Giovanni D’Angelo, Sylvie Lavallée, Anne Marinier, Sébastien Lemieux, Josée Hébert, Guy Sauvageau	23
12	A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens 2017 ·Blood Cancer Journal ·Irène Baccelli, Jana Krošl, Geneviève Boucher, Isabel Boivin, (unknown), Josée Hébert, Sébastien Lemieux, Anne Marinier, Guy Sauvageau	8
13	H3 K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations 2017 ·Blood ·Bernhard Lehnertz, (unknown), Isabel Boivin, Nadine Mayotte, Elisa Tomellini, Jalila Chagraoui, Vincent‐Philippe Lavallée, Josée Hébert, Guy Sauvageau	52
14	GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo 2016 ·Blood ·Caroline Pabst, Anne Bergeron, Vincent‐Philippe Lavallée, Jonathan R. Yeh, Patrick Gendron, Gudmundur L. Norddahl, Jana Krošl, Isabel Boivin, Éric Deneault, (unknown), Suzan Imren, Geneviève Boucher, Kolja Eppert, Tobias Herold, Stefan K. Bohlander, R. Keith Humphries, Sébastien Lemieux, Josée Hébert, Guy Sauvageau, Frédéric Barabé	115
15	Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors 2016 ·Blood ·Vincent‐Philippe Lavallée, Jana Krošl, Sébastien Lemieux, Geneviève Boucher, Patrick Gendron, Caroline Pabst, Isabel Boivin, Anne Marinier, Cynthia J. Guidos, Sylvain Meloche, Josée Hébert, Guy Sauvageau	49
16	Transcriptional Landscape of APL Identifies Aberrant Podoplanin Expression As a Defining Feature and Missing Link for the Bleeding Disorder of This Disease 2016 ·Blood ·Vincent‐Philippe Lavallée, Miriam Marquis, Marie-Ève Bordeleau, Jalila Chagraoui, Tara MacRae, Isabel Boivin, Geneviève Boucher, Patrick Gendron, Sébastien Lemieux, Arnaud Bonnefoy, Georges E. Rivard, Josée Hébert, Guy Sauvageau	2
17	Mutational and Transcriptomic Landscape of AML with Core-Binding Factor Rearrangements 2015 ·Blood ·Vincent‐Philippe Lavallée, Patrick Gendron, Geneviève Boucher, Sébastien Lemieux, Richard N. Armstrong, Isabel Boivin, Guy Sauvageau, Josée Hébert	2
18	Evaluation of VCH-759 monotherapy in hepatitis C infection 2009 ·Journal of Hepatology ·Curtis Cooper, Eric Lawitz, Peter Ghali, M. Rodríguez‐Torres, Frank Anderson, Samuel S. Lee, Jean Bédard, Nathalie Chauret, Roch Thibert, Isabel Boivin, Olivier Nicolas, (unknown)	52
19	961 GENOTYPIC AND PHENOTYPIC ANALYSIS OF HCV NS5B VARIANTS SELECTED FROM PATIENTS TREATED WITH VCH-916 2009 ·Journal of Hepatology ·(unknown), Isabel Boivin, (unknown), (unknown), F Denis, (unknown), Jean Bédard	11
20	844 GENOTYPIC ANALYSIS OF HCV NS5B VARIANTS SELECTED FROM PATIENTS TREATED WITH VCH-759 2008 ·Journal of Hepatology ·(unknown), Isabel Boivin, (unknown), Jean Bédard	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact